A Cause of Hyperinflammatory Response in Lethal COVID-19 Identified
Read Full ArticleLatest News
-
03/03/2025
Annual Mix 106.5 Radiothon Raises More Than $30 Million for Pediatric Patients at Johns Hopkins Over 36 Years
-
03/03/2025
Scientists Trace Genetic Roots of the Largest African Nomadic Group to Prehistoric Period
-
03/02/2025
Johns Hopkins Medicine Study Shows How Recently Approved Drug for Food Allergies Compares to Oral Immunotherapy, Whether It Allows Patients to Eat Their Food Allergens
Contact Johns Hopkins Media Relations
Johns Hopkins Medicine In the News
-
Can cold weather make you sick? Experts explain why more people feel ill in the winter
Today
Early in the fall, experts might also see more cases of respiratory syncytial virus, Dr. Geeta Sood, assistant professor of medicine and epidemiologist at Johns Hopkins Bayview Medical Center, tells Today.com. With COVID-19 in the mix, the dynamics of respiratory virus season have changed in the last few years, Sood says. -
This drug is the 'breakthrough of the year' -- and it could mean the end of the HIV epidemic
NPR
Ethel Weld, an assistant professor of medicine at the Johns Hopkins University School of Medicine, describes the results from the PURPOSE 1 and PURPOSE 2 trials as "a thrilling game changer for HIV prevention."